Vericiguat tablets/Verquvo

Vericiguat tablets are suitable for adult patients with symptomatic chronic heart failure with reduced ejection fraction (ejection fraction <45%) who have recently decompensated heart failure and whose condition has stabilized after intravenous treatment, in order to reduce the risk of hospitalization for heart failure or the need for emergency intravenous diuretic treatment.

Combination medication

Reasonable drug combination can enhance efficacy or reduce adverse drug reactions, but conversely can lead to reduced efficacy or increased toxicity, and may also cause some abnormal reactions, interfere with treatment, and aggravate the condition. Therefore, when patients take the medicine, do not use it with other drugs privately to avoid drug interactions. If you want to use it with other drugs at the same time, please consult a doctor or pharmacist before use.